Routine prenatal vaccine administration, such as that of influenza or tetanus, diphtheria, and acellular pertussis (Tdap), is a cornerstone of prenatal care and an important part of public health efforts to prevent disease. Respiratory syncytial virus (RSV) is a highly contagious virus that can result in severe respiratory complications, and infants, especially those younger than age 1, are particularly vulnerable to the dangers of RSV. While all infants can be exposed to and affected by RSV, underserved communities that experience systemic disadvantages face greater barriers to health care access. Uptake of prenatal vaccination in the United States remains low and a powerful educational initiative that provides expert analysis of the available data for maternal RSV vaccination is needed.
In this CMEO Webcast, expert faculty will discuss strategies to evaluate the latest data for RSV maternal vaccination, assess the impact of RSV disease on infants, pregnant individuals, and the health care system at large, particularly among underserved populations, and integrate actionable strategies to address real-world implementation-related challenges of maternal RSV vaccination, with a focus on guidelines and tools to overcome barriers to access.
This activity is supported by an educational grant from Pfizer, Inc.
OB/GYNs, family medicine physicians, maternal-fetal medicine specialists, nurse midwives, doulas, community health workers, nurse practitioners (NPs), nurse navigators, and physician associates (PAs)
In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education Credit for learning and change.
CME Outfitters, LLC, designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is designated for 1.00 contact hours.
This application-based activity is approved for 1.00 contact hours ( 0.1 CEUs) of continuing pharmacy credit ( JA0007185-0000-23-126-H01-P ).
CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until 12/07/2024. PAs should only claim credit commensurate with the extent of their participation.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Tan reports the following financial relationships:
Grants: AstraZeneca and GSK
Consultant: GSL; ILiAD Biotechnologies; Merck & Co., Inc.; Moderna, Inc.; Novavax; Pfizer Inc.; and Sanofi Pasteur
Dr. Ault reports no financial relationships to disclose.
Ms. Rouse reports no financial relationships to disclose.
Disclosures were obtained from the following peer reviewer and CME Outfitters, LLC, staff, with no disclosures to report:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Call us at 877.CME.PROS (877.263.7767).